75976 Concerns Regarding Dermatologic Side Effects Influencing Initiation and Dose of Testosterone Therapy in Gender Affirmation Care
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB125
DOI: 10.1016/j.jaad.2026.04.508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Seongbae Kong und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kong, S., Sobieraj, J., & Wang, F. (2026). 75976 Concerns Regarding Dermatologic Side Effects Influencing Initiation and Dose of Testosterone Therapy in Gender Affirmation Care. Journal of the American Academy of Dermatology, 95(1), AB125. https://doi.org/10.1016/j.jaad.2026.04.508
Vancouver
Kong S, Sobieraj J, Wang F. 75976 Concerns Regarding Dermatologic Side Effects Influencing Initiation and Dose of Testosterone Therapy in Gender Affirmation Care. Journal of the American Academy of Dermatology. 2026;95(1):AB125. doi:10.1016/j.jaad.2026.04.508
BibTeX
@article{Kong2026,
author = {Kong, Seongbae and Sobieraj, Jeffrey and Wang, Frank},
title = {75976 Concerns Regarding Dermatologic Side Effects Influencing Initiation and Dose of Testosterone Therapy in Gender Affirmation Care},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB125},
doi = {10.1016/j.jaad.2026.04.508}
}
EUVIMED